You are here: Home → News → Health → 2017 11 29 → Article 605205

Johnson & Johnson, partners announce first efficacy study for investigational mosaic HIV-1 preventive vaccine

Read Article

Comments (0)

This article is closed for comments.

Read Comments Comments (0)

No comments yet